Sign up
Quantellect · Congress · Trade Detail
CELGCelgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P)
DemocratHouse

Bradley Scott Schneider sold Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P) (CELG)

Bradley Scott Schneider (D-IL), a U.S. Representative, has disclosed 3 trades in Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P) (CELG) since 2017, 1 purchase and 2 sales, worth an estimated $525K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Bradley Scott Schneider sold $100,001 - $250,000 of Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P) (CELG) on October 23, 2017. Since that trade, CELG is up +0.00% against the S&P 500 up +230.72%, an outperformance of -230.72%.

Across these filings, Bradley Scott Schneider has been a net seller of CELG (a buy-to-sell ratio of 0.50). Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

CELG trades
3
Disclosed Vol
$525K
Buys
1
33%
Sells
2
67%
Buy / Sell
0.50
ratio
First → Last
2017

Bradley Scott Schneider's CELG trades vs the price

CELG is up +0.00% since Bradley Scott Schneider sold on October 23, 2017, versus +230.72% for the S&P 500.

Performance since this trade

Price change since trade
+0.00%
S&P 500 change since trade
+230.72%
Outperformance vs S&P 500
-230.72%

All Bradley Scott Schneider CELG trades

TradedTypeSizeReturnEst. profit
October 23, 2017SELL$100,001 - $250,000N/A
October 23, 2017SELL$100,001 - $250,000N/A
January 9, 2017BUY$100,001 - $250,000N/A

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Bradley Scott Schneider & CELG trading FAQ

Is it legal for Bradley Scott Schneider to trade Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P) (CELG) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P) (CELG), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Bradley Scott Schneider sell CELG?

Bradley Scott Schneider disclosed a sale of $100,001 - $250,000 of Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P) (CELG) on October 23, 2017, according to public STOCK Act filings.

How has CELG performed since Bradley Scott Schneider's trade?

Since Bradley Scott Schneider sold CELG on October 23, 2017, the stock is up +0.00%, versus +230.72% for the S&P 500 over the same period, an outperformance of -230.72%.

How many times has Bradley Scott Schneider traded CELG?

Bradley Scott Schneider has disclosed 3 CELG trades since 2017 (1 purchase and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional CELG trades?

Quantellect tracks every disclosed congressional trade in Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P) (CELG) on the Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P) congressional trading page, which aggregates filings across all members of Congress.

Bradley Scott Schneider's CELG tradesAll congressional filings for Celgene Corporation (CELG) F ILING S TaTUS : New S UBHoLDING o F : 16 - MSSB BRoKERaGE aCCoUNT - IRa (CD/P)Bradley Scott Schneider's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.